Cargando…
Rosa26-LSL-dCas9-VPR: a versatile mouse model for tissue specific and simultaneous activation of multiple genes for drug discovery
Transgenic animals with increased or abrogated target gene expression are powerful tools for drug discovery research. Here, we developed a CRISPR-based Rosa26-LSL-dCas9-VPR mouse model for targeted induction of endogenous gene expression using different Adeno-associated virus (AAV) capsid variants f...
Autores principales: | Pakalniškytė, Dalia, Schönberger, Tanja, Strobel, Benjamin, Stierstorfer, Birgit, Lamla, Thorsten, Schuler, Michael, Lenter, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649745/ https://www.ncbi.nlm.nih.gov/pubmed/36357523 http://dx.doi.org/10.1038/s41598-022-23127-7 |
Ejemplares similares
-
A gene therapy for inherited blindness using dCas9-VPR–mediated transcriptional activation
por: Böhm, Sybille, et al.
Publicado: (2020) -
AAV-Mediated Expression of Human VEGF, TNF-α, and IL-6 Induces Retinal Pathology in Mice
por: Weigelt, Carina M., et al.
Publicado: (2021) -
Versatile transcription control based on reversible dCas9 binding
por: Widom, Julia R., et al.
Publicado: (2019) -
Up-Regulating ERIC by CRISPR-dCas9-VPR Inhibits Cell Proliferation and Invasion and Promotes Apoptosis in Human Bladder Cancer
por: Yang, Jiangeng, et al.
Publicado: (2021) -
A novel fungal gene regulation system based on inducible VPR-dCas9 and nucleosome map-guided sgRNA positioning
por: Schüller, Andreas, et al.
Publicado: (2020)